No Data
Piper Sandler Reiterates Overweight on TransMedics Group, Raises Price Target to $105
CCORF Maintains TransMedics(TMDX.US) With Buy Rating, Maintains Target Price $104
Analysts Are Bullish on These Healthcare Stocks: Organon (OGN), TransMedics Group (TMDX)
TransMedics Group, Inc.'s (NASDAQ:TMDX) P/S Is Still On The Mark Following 33% Share Price Bounce
TransMedics to Report First Quarter 2025 Financial Results on May 8, 2025
Needham Reiterates Hold on TransMedics Groupto Hold